These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32382541)

  • 1. Improved Landmark Dynamic Prediction Model to Assess Cardiovascular Disease Risk in On-Treatment Blood Pressure Patients: A Simulation Study and Post Hoc Analysis on SPRINT Data.
    Sayadi M; Zare N; Attar A; Ayatollahi SMT
    Biomed Res Int; 2020; 2020():2905167. PubMed ID: 32382541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study.
    Hippisley-Cox J; Coupland C; Brindle P
    BMJ; 2017 May; 357():j2099. PubMed ID: 28536104
    [No Abstract]   [Full Text] [Related]  

  • 3. Dynamic prediction model and risk assessment chart for cardiovascular disease based on on-treatment blood pressure and baseline risk factors.
    Teramukai S; Okuda Y; Miyazaki S; Kawamori R; Shirayama M; Teramoto T
    Hypertens Res; 2016 Feb; 39(2):113-8. PubMed ID: 26606874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of repeated blood pressure measures for cardiovascular risk prediction: a comparison of statistical models in the ARIC study.
    Sweeting MJ; Barrett JK; Thompson SG; Wood AM
    Stat Med; 2017 Dec; 36(28):4514-4528. PubMed ID: 27730661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central Haemodynamics and Prediction of Cardiovascular Events in Patients With Erectile Dysfunction.
    Vlachopoulos C; Ioakeimidis N; Rokkas K; Angelis A; Terentes-Printzios D; Kratiras Z; Georgakopoulos C; Tousoulis D
    Am J Hypertens; 2017 Mar; 30(3):249-255. PubMed ID: 27927629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Long-term Cumulative Blood Pressure in Cardiovascular Risk Prediction Models.
    Pool LR; Ning H; Wilkins J; Lloyd-Jones DM; Allen NB
    JAMA Cardiol; 2018 Nov; 3(11):1096-1100. PubMed ID: 30193291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Estimated Pulse Wave Velocity With Survival: A Secondary Analysis of SPRINT.
    Vlachopoulos C; Terentes-Printzios D; Laurent S; Nilsson PM; Protogerou AD; Aznaouridis K; Xaplanteris P; Koutagiar I; Tomiyama H; Yamashina A; Sfikakis PP; Tousoulis D
    JAMA Netw Open; 2019 Oct; 2(10):e1912831. PubMed ID: 31596491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morning Home Blood Pressure and Cardiovascular Events in Japanese Hypertensive Patients.
    Kario K; Iwashita M; Okuda Y; Sugiyama M; Saito I; Kushiro T; Teramukai S; Shimada K
    Hypertension; 2018 Oct; 72(4):854-861. PubMed ID: 30354719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalizing the Intensity of Blood Pressure Control: Modeling the Heterogeneity of Risks and Benefits From SPRINT (Systolic Blood Pressure Intervention Trial).
    Patel KK; Arnold SV; Chan PS; Tang Y; Pokharel Y; Jones PG; Spertus JA
    Circ Cardiovasc Qual Outcomes; 2017 Apr; 10(4):. PubMed ID: 28373269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiometabolic risk: leg fat is protective during childhood.
    Samouda H; De Beaufort C; Stranges S; Hirsch M; Van Nieuwenhuyse JP; Dooms G; Gilson G; Keunen O; Leite S; Vaillant M; Lair ML; Dadoun F
    Pediatr Diabetes; 2016 Jun; 17(4):300-8. PubMed ID: 26083149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do the 2017 blood pressure cut-offs improve 10-year cardiovascular disease mortality risk prediction?
    Peng Y; Wang Z
    Nutr Metab Cardiovasc Dis; 2020 Oct; 30(11):2008-2016. PubMed ID: 32723581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular Risk Prediction Functions Underestimate Risk in HIV Infection.
    Triant VA; Perez J; Regan S; Massaro JM; Meigs JB; Grinspoon SK; D'Agostino RB
    Circulation; 2018 May; 137(21):2203-2214. PubMed ID: 29444987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction rule for cardiovascular events and mortality in peripheral arterial disease patients: data from the prospective Second Manifestations of ARTerial disease (SMART) cohort study.
    Sprengers RW; Janssen KJ; Moll FL; Verhaar MC; van der Graaf Y;
    J Vasc Surg; 2009 Dec; 50(6):1369-76. PubMed ID: 19837547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intensive blood pressure lowering on cardiovascular outcomes based on cardiovascular risk: A secondary analysis of the SPRINT trial.
    Attar A; Sayadi M; Jannati M
    Eur J Prev Cardiol; 2019 Feb; 26(3):238-245. PubMed ID: 30256671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. J-shaped relationship between cardiovascular risk and efficacy of intensive blood pressure reduction: A post-hoc analysis of the SPRINT trial.
    Attar A; Nouri F; Borazjani R; Sayadi M
    PLoS One; 2020; 15(10):e0240102. PubMed ID: 33002071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of Firth-and logF-type penalized methods in risk prediction for small or sparse binary data.
    Rahman MS; Sultana M
    BMC Med Res Methodol; 2017 Feb; 17(1):33. PubMed ID: 28231767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood Pressure Variability Predicts Adverse Events and Cardiovascular Outcomes in Chronic Kidney Disease: A Post-Hoc Analysis of the SPRINT Trial.
    Mezue K; Goyal A; Pressman GS; Horrow JC; Rangaswami J
    Am J Hypertens; 2017 Dec; 31(1):48-52. PubMed ID: 28985328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of cardiovascular events in subjects in the second Australian National Blood Pressure study.
    Nelson MR; Ryan P; Tonkin AM; Ramsay E; Willson K; Wing LW; Reid CM;
    Hypertension; 2010 Jul; 56(1):44-8. PubMed ID: 20497992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of predictive models for long-term cardiovascular risk associated with systolic and diastolic blood pressure.
    Glynn RJ; L'Italien GJ; Sesso HD; Jackson EA; Buring JE
    Hypertension; 2002 Jan; 39(1):105-10. PubMed ID: 11799087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Risk of Harm Associated With Intensive Blood Pressure Management Among Patients With Hypertension Who Smoke: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial.
    Scarpa J; Bruzelius E; Doupe P; Le M; Faghmous J; Baum A
    JAMA Netw Open; 2019 Mar; 2(3):e190005. PubMed ID: 30848803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.